MIF

MIF

MIF Informations sur la molécule

Molecule Name
Macrophage migration inhibitory factor
Alias de la molécule
MIF,GLIF,MMIF,GIF
Drug Development Progress
Nombre de médicaments cliniques3
Nombre de médicaments commercialisés1
Phase de R&D la plus avancéeApproved
Alias de la cible
EC:5.3.2.1,GIF,EC 5.3.3.12,EC 5.3.2.1,Macrophage Migration-Inhibitory Factors,Epididymis Secretory Sperm Binding Protein,EC:5.3.3.12,Phenylpyruvate Tautomerase,L-Dopachrome Tautomerase,MMIF,Glycosylation-inhibiting factor,L-dopachrome isomerase,MIF,Macrophage Migration Inhibitory Factor,Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor),GLIF
Contexte de la molécule
Macrophage migration inhibitory factor(MIF) is also known as Glycosylation-inhibiting factor(GIF), L-dopachrome isomerase, L-dopachrome tautomerase, Phenylpyruvate tautomerase. Interacts with CXCR2 extracellular domain, CD74 extracellular domain, COPS5 and BNIPL. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.

MIF Liste de produits

Species
  • Human(1)
Tag
  • His Tag & Avi Tag(1)
Host
  • HEK293(1)
Conjugate
  • Biotin-labeled(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
MoleculeCat. No.Product NameEspèceHostStructurePurityActivitySize&PriceAdd to Cart
MIF
Avitag
MIF-H82E7
Biotinylated Human MIF Protein, His,Avitag™
Human
HEK293
SDS-PAGE

$360.00

25ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
IPG-1094IPG-1094; IPG-001Phase 2 ClinicalNanjing Immunophage Biotech Co Ltd
Brain metastases; Brain Neoplasms; Hematologic Neoplasms; Lupus Nephritis; Multiple Myeloma; Multiple Sclerosis; Psoriasis; Solid tumours
Details
TRP2-electroporated autologous dendritic cell therapy (Memorial Sloan-Kettering)Phase 1 ClinicalMemorial Sloan Kettering Cancer Center
Melanoma
Details
STP-1STP-1; STP1Phase 1 ClinicalStalicla Sa
Autism Spectrum Disorder
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
IbudilastKC-404; AV-411; MN-166ApprovedKyorin Pharmaceutical Co LtdKetas, Pinatos, EyevinalJapanAsthma; Multiple Sclerosis; NeuralgiaKyorin Pharmaceutical Co Ltd
Alcoholism; Amyotrophic Lateral Sclerosis; Asthma; Diabetic Neuropathies; Headache Disorders, Secondary; HIV Infections; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Neuralgia; Opioid-Related Disorders; Pneumonia, Viral; Substance-Related Disorders
Details
Customer Reviews
  • S***n2023-04-28
    This product was used for characterization of a novel therapeutic testing kinetics and affinity on SPR with a Cytiva BiotinCAPture kit. It worked phenomenally with both the novel approach and a positive control. Additionally, it was used with a Streptavidin coated ELISA plate (also from Acro), results were phenomenal with that approach as well. Overall, this product has been well received by our team and we have already ordered more to continue testing.